Literature DB >> 23946308

Microglia: Multiple roles in surveillance, circuit shaping, and response to injury.

Eduardo E Benarroch1.   

Abstract

Microglial cells are the immune cells in the CNS and represent approximately 10% of the total brain cell population. Their morphologic characterization by Pio del Rio-Hortega was first published almost a century ago, but the understanding of their function in the normal and injured CNS is still incomplete. Classically, microglia have been classified into 2 main types: "resting" microglia, with a ramified morphology, present in the uninjured CNS; and "activated" microglia, with an amoeboid morphology, present at the sites of injury. However, morphologic, molecular, and genetic studies indicate that this subdivision is a misleading oversimplification. Resting microglia actively survey their environment; activated microglia constitute a heterogeneous population that dynamically changes in phenotype depending on the type of stimulus and microenvironment, participating not only in mechanisms of injury but also in neuroprotection, repair, and circuit refinement in the CNS. The primary role of microglia is therefore to maintain cellular, synaptic, and myelin homeostasis both during development and normal function of the CNS and in response to CNS injury. Microglia have been implicated in mechanisms of CNS trauma, stroke, infection, demyelination, neoplasm, and neurodegeneration. Microglial dysfunction may also contribute to genetic neurobehavioral disorders, such as Rett syndrome. There are several comprehensive reviews on all these topics.

Entities:  

Mesh:

Year:  2013        PMID: 23946308     DOI: 10.1212/WNL.0b013e3182a4a577

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  84 in total

Review 1.  Functional neural-bone marrow pathways: implications in hypertension and cardiovascular disease.

Authors:  Jasenka Zubcevic; Monica M Santisteban; Teresa Pitts; David M Baekey; Pablo D Perez; Donald C Bolser; Marcelo Febo; Mohan K Raizada
Journal:  Hypertension       Date:  2014-03-31       Impact factor: 10.190

Review 2.  Modulation of learning and memory by cytokines: signaling mechanisms and long term consequences.

Authors:  Elissa J Donzis; Natalie C Tronson
Journal:  Neurobiol Learn Mem       Date:  2014-08-21       Impact factor: 2.877

Review 3.  Innate immune activation in Alzheimer's disease.

Authors:  Ming-Ming Wang; Dan Miao; Xi-Peng Cao; Lin Tan; Lan Tan
Journal:  Ann Transl Med       Date:  2018-05

Review 4.  [Neuroinflammation as motor of Alzheimer's disease].

Authors:  Sergio Castro-Gomez; Julius Binder; Michael T Heneka
Journal:  Nervenarzt       Date:  2019-09       Impact factor: 1.214

5.  Inflammation and immune system activation after traumatic brain injury.

Authors:  Ramani Balu
Journal:  Curr Neurol Neurosci Rep       Date:  2014-10       Impact factor: 5.081

Review 6.  Novel therapeutic approaches in multiple system atrophy.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2014-06-14       Impact factor: 4.435

7.  Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis.

Authors:  Christina Sundal; Matt Baker; Rosa Rademakers; Oluf Andersen; Virginija Karrenbauer; Marte Gustavsen; Sahl Bedri; Anna Glaser; Kjell-Morten Myhr; Kristoffer Haugarvoll; Henrik Zetterberg; Hanne Harbo; Ingrid Kockum; Jan Hillert; Zbigniew Wszolek
Journal:  Eur J Neurol       Date:  2014-10-13       Impact factor: 6.089

8.  TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice.

Authors:  Jing Wen; Jessica Doerner; Karen Weidenheim; Yumin Xia; Ariel Stock; Jennifer S Michaelson; Kuti Baruch; Aleksandra Deczkowska; Maria Gulinello; Michal Schwartz; Linda C Burkly; Chaim Putterman
Journal:  J Autoimmun       Date:  2015-04-22       Impact factor: 7.094

Review 9.  Neuroimmune Response in Ischemic Preconditioning.

Authors:  Ashley McDonough; Jonathan R Weinstein
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

10.  Correction to: Neuroimmune Response in Ischemic Preconditioning.

Authors:  Ashley McDonough; Jonathan R Weinstein
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.